RT Journal Article
SR Electronic
A1 Nierengarten, Mary Beth
T1 Negative Results End Development Program of Treating JIA with GLM
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 51
SP 17
OP 18
DO 10.1177/155989771451013
UL http://mdc.sagepub.com/content/14/51/17.abstract
AB This article presents the 48-week results of the Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis and Multiple Joint Involvement Who Have Poor Response to Methotrexate [GO KIDS; NCT01230827].